Kevin J. McNamara
2019
In 2019, Kevin J. McNamara earned a total compensation of $10M as President and CEO at Chemed, a 14% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $48,969 |
|---|---|
| Non-Equity Incentive Plan | $2,409,428 |
| Option Awards | $3,411,139 |
| Salary | $1,217,317 |
| Stock Awards | $1,702,215 |
| Other | $1,230,782 |
| Total | $10,019,850 |
McNamara received $3.4M in option awards, accounting for 34% of the total pay in 2019.
McNamara also received $49K of change in pension value and nonqualified deferred compensation earnings, $2.4M in non-equity incentive plan, $1.2M in salary, $1.7M in stock awards and $1.2M in other compensation.
Rankings
In 2019, Kevin J. McNamara's compensation ranked 748th out of 13,971 executives tracked by ExecPay. In other words, McNamara earned more than 94.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 748 out of 13,971 | 95th |
Division Services | 168 out of 2,389 | 93rd |
Major group Health Services | 13 out of 237 | 95th |
Industry group Home Health Care Services | 2 out of 29 | 93rd |
Industry Home Health Care Services | 2 out of 29 | 93rd |
Source: SEC filing on April 9, 2020.
McNamara's colleagues
We found four more compensation records of executives who worked with Kevin J. McNamara at Chemed in 2019.